Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

Molecular Partners Ag (MOLN) EBT (2021 - 2025)

Historic EBT for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15.1 billion.

  • Molecular Partners Ag's EBT fell 11505936388.39% to -$15.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 billion, marking a year-over-year decrease of 8533436.36%. This contributed to the annual value of -$61.4 million for FY2024, which is 1209.17% up from last year.
  • Molecular Partners Ag's EBT amounted to -$15.1 billion in Q3 2025, which was down 11505936388.39% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's EBT ranged from a high of $165.2 billion in Q1 2022 and a low of -$20.5 billion during Q1 2021
  • Moreover, its 5-year median value for EBT was -$16136.5 (2025), whereas its average is $9.9 billion.
  • Per our database at Business Quant, Molecular Partners Ag's EBT soared by 98236.61% in 2024 and then plummeted by 11505936388.39% in 2025.
  • Molecular Partners Ag's EBT (Quarter) stood at $51.7 billion in 2021, then crashed by 99.76% to $122.2 million in 2022, then tumbled by 100.76% to -$934828.2 in 2023, then surged by 982.37% to $8.2 million in 2024, then tumbled by 182641.67% to -$15.1 billion in 2025.
  • Its last three reported values are -$15.1 billion in Q3 2025, $4.7 million for Q2 2025, and -$16136.5 during Q1 2025.